MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MTVA is expected to report earnings to rise 3.80% to -81 cents per share on August 18
Q2'26
Est.
$-0.82
Q1'26
Missed
by $0.45
Q4'25
Missed
by $0.52
Q3'25
Beat
by $0.18
Q2'25
Beat
by $0.06
The last earnings report on May 14 showed earnings per share of -79 cents, missing the estimate of -34 cents. With 258.04K shares outstanding, the current market capitalization sits at 8.16M.